New vaccine shots, tailored to the BA.5 variant could soon be around the corner, as announced that it has submitted a bid to have its new shot approved by the .The New York City-based firm, which has partnered with the German company BioNTech is the development and manufacturing of the shots, announced that it made its submission to the Food and Drug Administration (FDA) on Monday.It is a long-awaited move, with experts having discussed the prospect of a new, Omicron-specific, vaccine since the end of 2021 - when it first became clear the virus had evolved an ability to evade protection against infection provided by the shots.
Load More
Load More